0001140361-16-087794.txt : 20161123
0001140361-16-087794.hdr.sgml : 20161123
20161123164200
ACCESSION NUMBER: 0001140361-16-087794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161121
FILED AS OF DATE: 20161123
DATE AS OF CHANGE: 20161123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 162017083
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
4
1
doc1.xml
FORM 4
X0306
4
2016-11-21
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2016-11-21
2016-11-21
4
M
0
69744
26.490
A
240426
D
Common Stock
2016-11-21
2016-11-21
4
S
0
69744
87.5556
D
170682
D
Common Stock
2016-11-22
2016-11-22
4
M
0
69743
26.490
A
240425
D
Common Stock
2016-11-22
2016-11-22
4
S
0
69743
85.6934
D
170682
D
Common Stock
182801
I
Shares held by Jean-Jacques Bienaime Family Trust
Stock Option (right to buy Common Stock)
26.49
2016-11-21
2016-11-21
4
M
0
69744
0
D
2011-11-12
2021-05-11
Common Stock
69744
210256
D
Stock Option (right to buy Common Stock)
26.49
2016-11-22
2016-11-22
4
M
0
69743
0
D
2011-11-12
2021-05-11
Common Stock
69743
140513
D
Trade made pursuant to a 10b5-1 plan executed on June 9, 2016. Mr. Bienaime's former spouse will receive the net proceeds from the shares sold in this transaction in connection with cash payments owed to her pursuant to a marital separation agreement between her and Mr. Bienaime.
The amount of securities beneficially owned has been updated from the reporting person's prior Form 4 to reflect (a) changes in the form of ownership due to transfers made by the reporting person between accounts held directly and indirectly in the name of the Bienaime Family Trust and the Jean-Jacques Bienaime Family Trust and (b) an additional 4,357 shares beneficially owned by the reporting person pursuant to a reconciliation of the Company's records following the completion of the transfer of shares in connection with the reporting person's marital separation agreement.
The price in column 4 is the weighted average price. The price actually received ranged from $86.74 to $89.59. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
The price in column 4 is the weighted average price. The price actually received ranged from $84.45 to $88.16. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2016-11-23